In univariate analysis of the patients with NSCLC and BRAF mutation, female patients had marginally significantly longer OS (vs. males; HR = 0.527; 95% CI: 0.193–1.090; P = 0.094). Here, BRAF is linked to non-small cell lung carcinoma.